Based on our previous work and the premise that the effects of phenformin on individual breast cancer subtypes have not been fully explored, it is intriguing to explore the effects of phenformin on ErbB2-overexpressing breast cancer models. This evidence concerns the gene ERBB2 and breast carcinoma.